Nicolas Marcoux

<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Nicolas Marcoux, Scott Gettinger, Grainne M. O’Kane et al. · Journal of Clinical Oncology · 2018 · 471 citations

Medicine, Oncology, Pathology +17

Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i> -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> Fusion

Zofia Piotrowska, Hideko Isozaki, Jochen K. Lennerz et al. · Cancer Discovery · 2018 · 445 citations

Medicine, Oncology, Pharmacology +17

Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre study

Antoine Desîlets, Félix Blanc‐Durand, Sally C. M. Lau et al. · European Journal of Cancer · 2020 · 78 citations

Medicine, Oncology, Radiation Oncology +14

Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study

Frédéric Pouliot, Fred Saad, Étienne Rousseau et al. · Journal of Nuclear Medicine · 2024 · 26 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

Sreya Duttagupta, Meriem Messaoudene, Sebastian Hunter et al. · Nature Medicine · 2026 · 25 citations · Full text

Life Sciences, Immunology, Oncology +17